Home blood testing for insurers, so members can complete the check at home
Aniva supplies the kits, the shipping, the accredited laboratory and the results interface, so your members give a sample at home and your team runs the programme rather than the logistics. Aniva is best for funds whose screening invitations go out but are rarely acted on quickly, because every sample has a status your programme can see.
The kit arrives in your own envelope
What Aniva supplies and what your fund keeps
Diagnostics as a service means that one supplier provides the collection kits, the shipping, the accredited laboratory and the results interface, so that another company can run blood testing under its own name.
Your fund designs the programme and Aniva runs what happens to the sample, so the only part that changes is the posting, the collection and the laboratory work.
The invitation is not where your programme loses people
The published German evaluation of the bowel cancer screening programme shows what happens after the letter, and its clearest finding is how long people wait before they act on it. The same gap is visible across Europe, where 42 percent of people in the target age group were screened for bowel cancer in the previous two years in 2022.
Almost everybody is invited
Between 2020 and 2023 an average of 89.5 percent of eligible insured people received an information letter from their fund, so the invitation is reaching almost everybody.
Very few act on the letter
Fewer than 7 percent of those invited were examined within the first three months, and the median gap between the invitation and the examination was 336 days.
The follow up is badly documented
A documented follow up colonoscopy could be linked to 12.9 percent of positive stool tests, and the evaluation calls that a lower bound because much of the real follow up was coded wrongly.
Completion is the number that decides whether it worked
If the letter is not the problem, then the number that matters is how many members finish, and these are the figures for that today.
What that looks like from the envelope to the result
Running the programme has four steps, and your team runs none of the logistics in any of them.
You choose the member group
Your programme decides who is invited and what the panel contains, and Aniva produces the kit in your design.
The member collects at home
The kit arrives with instructions, and a member who needs a venous draw books one at a partner location instead.
An accredited laboratory analyses it
A partner laboratory accredited to ISO 15189 and working to RiliBÄK, the German quality guideline for medical laboratories, runs the panel, and a sample that fails is flagged for a redraw.
You see completion rather than guesses
Structured results and status events tell your programme who finished, who did not and where each sample stopped.
The published figures your team already knows
These are the numbers a prevention team quotes internally, and they are what any pilot is measured against. The German picture is not unusual, because across the EU 55.3 percent of people aged 15 and over had their cholesterol measured by a health professional in the year before the survey.
per insured person was spent on primary prevention and health promotion in the 2024 reporting year
was the total for primary prevention and health promotion in that year
of insured people aged 35 and over used the general health check in 2021, which is the yearly rate
general health checks were billed in Germany in 2024, which is 11.3 percent more than in 2023
Who is responsible for each part of it
This is the split as it is written into the contract, so you can see which parts are ours and which stay with you.
Who does what
Running it in house
With Aniva
The questions prevention and care teams ask next
Teams at this point ask about branding, evidence of completion and where the data goes, and these are the answers.
Yours, because the kit box, the instructions, the shipping carton and the result document are all produced in your design.
Every sample has a status, and a sample that cannot be measured is flagged in your console so that a redraw is arranged rather than the member simply hearing nothing.
Processing is in Germany under the GDPR, and the analysis is run by a partner laboratory that is accredited to ISO 15189 and works to RiliBÄK.
No, because that is a decision for your own legal and contracting people, and Aniva describes only what it operates rather than what your fund may finance.
Yes, because a member can book a venous draw at one of over 25 partner locations across Germany instead of collecting at home.
Four weeks from a signed contract to the first draw is normal for a defined group of members and a defined panel.
Sources on this page. Prevention spend under paragraphs 20 ff. SGB V: GKV-Spitzenverband and Medizinischer Dienst Bund, Praeventionsbericht 2025, reporting year 2024. Check participation: Wissenschaftliches Institut der AOK, analysis of early detection uptake 2007 to 2021, published October 2022. Invitation, timing and follow up figures: G-BA oKFE-Evaluationsbericht Darmkrebs, data years 2021 to 2024, published 16 March 2026. European bowel cancer screening rate: OECD and European Commission, Health at a Glance Europe 2024, figures for 2022. European cholesterol measurement rate: Eurostat, Screening of cardiovascular diseases and diabetes risks, European Health Interview Survey wave three, 2019. Health check volume: Zentralinstitut fuer die kassenaerztliche Versorgung, Zi-Trendreport 2024, published 2025.
What happens on the call
Bring one member group and one panel, and we will describe every step, from the envelope the member opens to the completion figure your programme reports.